<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Ibutilide is more effective than sotalol for acute reversion of atrial tachyarrhythmias</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Ibutilide is more effective than sotalol for acute reversion of atrial tachyarrhythmias</h1>
<div class="graphic"><div class="figure"><div class="ttl">Ibutilide is more effective than sotalol for acute reversion of atrial tachyarrhythmias</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Among 281 patients with atrial fibrillation or atrial flutter randomized to intravenous ibutilide or intravenous sotalol, both doses of ibutilide were more effective than sotalol for reverting atrial flutter. Among the patients with atrial fibrillation, only the higher dose of ibutilide was significantly more effective than sotalol for restoring sinus rhythm.</div><div class="graphic_footnotes">* p &lt;0.05 compared with sotalol.<br/>â€¢ p &lt;0.05 compared with 1 mg ibutilide.</div><div class="graphic_reference">Data from: Vos MA, Golitsyn SR, Stangl K, et al. for the Ibutilide/Sotalol Comparator Study Group, Heart 1998; 79:568.</div><div id="graphicVersion">Graphic 51703 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
